Kaouthar Lbiati - 19 Feb 2024 Form 4 Insider Report for Hepion Pharmaceuticals, Inc. (HEPA)

Role
Director
Signature
/s/ Kaouthar Lbiati
Issuer symbol
HEPA
Transactions as of
19 Feb 2024
Net transactions value
$0
Form type
4
Filing time
21 Feb 2024, 20:01:38 UTC
Previous filing
20 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HEPA Stock Options Award $0 +85,000 +2833% $0.000000 88,000 19 Feb 2024 Common Stock 85,000 $2.56 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.